{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:22:19Z","timestamp":1788376939425,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbrc.2015.07.094","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T06:34:08Z","timestamp":1437546848000},"page":"1145-1150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Selective inhibition of TNFR1 reduces osteoclast numbers and is differentiated from anti-TNF in a LPS-driven model of inflammatory bone loss"],"prefix":"10.1016","volume":"464","author":[{"given":"A.I.","family":"Espirito Santo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ersek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Freidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Stoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6344-1677","authenticated-orcid":false,"given":"N.J.","family":"Horwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.07.094_bib1","doi-asserted-by":"crossref","first-page":"ii52","DOI":"10.1136\/annrheumdis-2012-202199","article-title":"Bone remodelling in inflammatory arthritis","volume":"72","author":"Goldring","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2015.07.094_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00223-013-9764-0","article-title":"Cells of the Immune System Orchestrate Changes in Bone Cell Function","volume":"94","author":"Wythe","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bbrc.2015.07.094_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"issue":"35","key":"10.1016\/j.bbrc.2015.07.094_bib4","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1016\/S0021-9258(19)61511-5","article-title":"Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis","volume":"275","author":"Abu-Amer","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.07.094_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and Paradoxical Effects of TNF-\u03b1 on Bone Homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2015.07.094_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbrc.2015.07.094_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm939","article-title":"TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases","volume":"9","author":"Feldmann","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2015.07.094_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/31.5.293","article-title":"TNF alpha\u2013a pivotal role in rheumatoid arthritis?","volume":"31","author":"Brennan","year":"1992","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bbrc.2015.07.094_bib9","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2015.07.094_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2013-204577","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"73","author":"Nam","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrc.2015.07.094_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cytogfr.2014.03.004","article-title":"Regulation and dysregulation of tumor necrosis factor receptor-1","volume":"25","author":"Puim\u00e8ge","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrc.2015.07.094_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00774-007-0834-0","article-title":"Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in\u00a0vivo","volume":"26","author":"Hussain Mian","year":"2008","journal-title":"J.\u00a0Bone Min. Metab."},{"key":"10.1016\/j.bbrc.2015.07.094_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1084\/jem.20021845","article-title":"Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production","volume":"197","author":"Horwood","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2015.07.094_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jbmr.210","article-title":"Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts","volume":"26","author":"Danks","year":"2011","journal-title":"J.\u00a0Bone Min. Res. Off. J. Am. Soc. Bone Min. Res."},{"key":"10.1016\/j.bbrc.2015.07.094_bib15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2010-05-282855","article-title":"Inhibition of osteoclast function reduces hematopoietic stem cell numbers in\u00a0vivo","volume":"117","author":"Lymperi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.07.094_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J.\u00a0Bone Min. Res. Off. J. Am. Soc. Bone Min. Res."},{"key":"10.1016\/j.bbrc.2015.07.094_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood-2007-03-082800","article-title":"Strontium can increase some osteoblasts without increasing hematopoietic stem cells","volume":"111","author":"Lymperi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.07.094_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.5650040116","article-title":"Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in\u00a0vitro","volume":"4","author":"Pfeilschifter","year":"1989","journal-title":"J.\u00a0Bone Min. Res. Off. J. Am. Soc. Bone Min. Res."},{"key":"10.1016\/j.bbrc.2015.07.094_bib19","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.34403","article-title":"Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis","volume":"64","author":"Vattakuzhi","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2015.07.094_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/endo.132.3.8440191","article-title":"The effect of leukemia inhibitory factor on bone in\u00a0vivo","volume":"132","author":"Cornish","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2015.07.094_bib21","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/IAI.67.8.4231-4236.1999","article-title":"Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide","volume":"67","author":"Chiang","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2015.07.094_bib22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00774-011-0270-z","article-title":"The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-\u03b1-induced bone resorption lacunae on mouse calvariae","volume":"29","author":"Nagano","year":"2011","journal-title":"J.\u00a0Bone Min. Metab."},{"key":"10.1016\/j.bbrc.2015.07.094_bib23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.38055","article-title":"Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures","volume":"65","author":"Schmidt","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2015.07.094_bib24","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.38755","article-title":"Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis","volume":"66","author":"McCann","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbrc.2015.07.094_bib25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.37797","article-title":"Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis","volume":"65","author":"Binder","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2015.07.094_bib26","first-page":"081018","article-title":"Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis","author":"Emery","year":"2009","journal-title":"J.\u00a0Rheumatol. Rheum."},{"key":"10.1016\/j.bbrc.2015.07.094_bib27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10875-013-9902-5","article-title":"Chronic recurrent multifocal osteomyelitis","volume":"33","author":"Costa-Reis","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.bbrc.2015.07.094_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3892\/ijmm.2013.1416","article-title":"Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-\u03b1 inhibits titanium particle-induced osteoclastogenesis and bone resorption","volume":"32","author":"Guo","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2015.07.094_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/art.33459","article-title":"Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis","volume":"64","author":"Vasudevan","year":"2012","journal-title":"Arthritis Rheum."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15303247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T18:55:19Z","timestamp":1652900119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15303247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0006291X15303247"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.094","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of TNFR1 reduces osteoclast numbers and is differentiated from anti-TNF in a LPS-driven model of inflammatory bone loss","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}